The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Regeneron Announces Upcoming 2013 Investor Conference Presentations

Thursday, April 18, 2013

Regeneron Announces Upcoming 2013 Investor Conference Presentations

09:30 EDT Thursday, April 18, 2013

TARRYTOWN, N.Y., April 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Baird's 2013 Growth Stock Conference on Wednesday, May 8, 2013.  The presentation is scheduled for 10:45 a.m. Eastern Time (9:45 a.m. Central Time).
  • Credit Suisse 2013 Antibody Day on Friday, May 10, 2013.  The presentation is scheduled for 7:45 a.m. Eastern Time.
  • Bank of America Merrill Lynch 2013 Healthcare Conference on Tuesday, May 14, 2013.  The presentation is scheduled for 6:40 p.m. Eastern Time (3:40 p.m. Pacific Time).

The presentations may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information: 

Manisha Narasimhan, Ph.D. 

Peter Dworkin

Investor Relations

Corporate Communications                           

914.847.5126

914.847.7640             

manisha.narasimhan@regeneron.com  

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections